PERIACTIN

This brand name is authorized in Ecuador, Estonia, Spain, Japan, United Kingdom, South Africa

Active ingredients

The drug PERIACTIN contains one active pharmaceutical ingredient (API):

1 Cyproheptadine UNII NJ82J0F8QC - CYPROHEPTADINE HYDROCHLORIDE

Cyproheptadine is a first generation antihistamine which also has anticholinergic and antiserotonergic activities that is used to treat allergic conditions including seasonal rhinitis, conjunctivitis, dermatitits and urticaria. Read about Cyproheptadine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AX02	Cyproheptadine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 03512-MAE-03-05
Country: EE	Ravimiamet	Identifier(s): 1807264
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 35622
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 23579
Country: JP	医薬品医療機器総合機構	Identifier(s): 4419005B1045, 4419005F1047, 4419005Q1072
Country: ZA	Health Products Regulatory Authority	Identifier(s): A40/5.7.1/0161